Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: A view from the ARAMIS database

American Journal of Therapeutics

Volumn 7, Issue 2, 2000, Pages 115-121

  Singh, Gurkirpal ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Acetaminophen; Gastrointestinal toxicity; Nonsteroidal anti inflammatory drug; Over the counter dose; Paracetamol

Indexed keywords

NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; DATA BASE; GASTROINTESTINAL DISEASE; HUMAN; INFORMATION SYSTEM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATABASES; DRUGS, NON-PRESCRIPTION; GASTROINTESTINAL DISEASES; HUMANS; INFORMATION SYSTEMS;

EID: 0034157957     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200007020-00008     Document Type: Review

References (37)

1. Butt JH, Barthel JS, Moore RA: Clinical spectrum of the upper gastrointestinal effects of nonsteroidal antiinflammatory drugs. Natural history, symptomatology, and significance. Am J Med 1988;84:5-14.
2. Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999,340:1888-1899.
3. Singh G, Triadafilopoulos G: Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999;26:18-24.
4. Singh G, Fries JF, Spitz P, Williams CA: Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective. Arthritis Rheum 1989,32:837-843.
5. Singh G, Fries JF, Williams CA, et al: Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 1991;18:188-194.
6. Singh G, Ramey DR, Morfeld D, et al: Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996;156: 1530-1536.
7. Hardin JG, Longenecker GL: Handbook of Drug Therapy in Rheumatic Disease: Pharmacology and Clinical Aspects. Little, Brown, Boston, 1992.
8. Goldenberg DL, Cohen AS: Drugs in the Rheumatic Diseases. Grune and Stratton, New York, 1986.
9. Scholes D, Stergachis A, Penna PM, et al: Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis. J Rheumatol 1995;22:708-712.
10. Ehsanullah RS, Page MC, Tildesley G, Wood JR: Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988;297:1017-1021.
11. Graham DY, Smith JL: Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988;83: 1081-1084.
12. Cryer B: Nonsteroidal anti-inflammatory drug gastrointestinal toxicity. Curr Opin Gastroenterol 1999;15:473-480.
13. Singh G, Ramey DR, Balise R, Triadafilopolous G: Epidemiology of NSAID-related GI complications in patients with osteoarthritis (OA): a 13 year prospective study [abstract]. Arthritis Rheum 1998;41:S180.
14. Fries JF, Ramey DR, Singh G, et al: A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med 1993;153:2465-2471.
15. Singh G: Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998;105: 31S-38S.
16. Armstrong CP, Blower AL: Non-steroidal antiinflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-532.
17. National Center for Health Statistics: 1998. Hyattsville, MD.
18. Bjorkman DJ: Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996;101:25S-32S.
19. Longstreth GF: Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995;90:206-210.
20. Greene JM, Winickoff RN: Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions. Arch Intern Med 1992; 152:1995-2002.
21. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-796.
22. Griffin MR, Piper JM, Daugherty JR, et al: Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-263.
23. Langman MJ, Weil J, Wainwright P, et al: Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-1078.
24. Garcia RL, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-772.
25. Hallas J, Lauritsen J, Villadsen HD, Gram LF: Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995;30:438-444.
26. Nielsen JC, Bjerring P, Arendt-Nielsen L: A comparison of the hypoalgesic effect of paracetamol in slow-release and plain tablets on laser-induced pain. Br J Clin Pharmacol 1991;31:267-270.
27. Hochain R, Berkelmans I, Czernichow P, et al: Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study. Eur J Gastroenterol Hepatol 1995;7:419-426.
28. Piper JM, Ray WA, Daughterly JR, Griffin MR: Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991;114:735-740.
29. Silverstein FE, Graham DY, Senior JR, et al: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-249.
30. Shorr RI, Ray WA, Daugherty JR, Griffin MR: Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993;153:1665-1670.
31. Singh G, Ramey DR, Triadafilopolous G, et al: GI SCORE: A simple self-assessment instrument to quantify the risk of serious NSAID-related GI complications in RA and OA [abstract]. Arthritis Rheum 1998;41:S75.
32. Wilcox CM, Shalek KA, Cotsonis G: Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med 1994;154:42-46.
33. Peura DA, Lanza FL, Gostout CJ, Foutch PG: The American College of Gastroenterology Bleeding Registry: preliminary findings [abstract]. Am J Gastroenterol 1997;92: 924-928.
34. Blot W, McLaughlin J: GI bleeding in relation to analgesic use [abstract]. Digestion 1998;59:207.
35. Levy M, Miller DR, Kaufman DW, et al: Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med 1988;148:281-285.
36. Weil J, Colin-Jones D, Langman M, et al: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310: 827-830.
37. Cryer B, Feldman M: Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999;117:17-25.